Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists found that the CCAAT/Enhancer-binding protein delta (CEBPD) protein levels in glioblastoma patients were significantly increased and further contributed to temozolamide resistance by promoting glioma-like stem cell formation.
[Cell Death Discovery]
6445212 {6445212:34GWVJAT} apa 50 1 157862 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-972e966421b649dd99acbb5af3f96a18%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2234GWVJAT%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWang%2C%20S.-M.%2C%20Lin%2C%20W.-C.%2C%20Lin%2C%20H.-Y.%2C%20Chen%2C%20Y.-L.%2C%20Ko%2C%20C.-Y.%2C%20%26amp%3B%20Wang%2C%20J.-M.%20%282021%29.%20CCAAT%5C%2FEnhancer-binding%20protein%20delta%20mediates%20glioma%20stem-like%20cell%20enrichment%20and%20ATP-binding%20cassette%20transporter%20ABCA1%20activation%20for%20temozolomide%20resistance%20in%20glioblastoma.%20%3Ci%3ECell%20Death%20Discovery%3C%5C%2Fi%3E%2C%20%3Ci%3E7%3C%5C%2Fi%3E%281%29%2C%201%26%23x2013%3B11.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41420-020-00399-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41420-020-00399-4%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D34GWVJAT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CCAAT%5C%2FEnhancer-binding%20protein%20delta%20mediates%20glioma%20stem-like%20cell%20enrichment%20and%20ATP-binding%20cassette%20transporter%20ABCA1%20activation%20for%20temozolomide%20resistance%20in%20glioblastoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shao-Ming%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen-Chi%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong-Yi%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yen-Lin%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiung-Yuan%22%2C%22lastName%22%3A%22Ko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ju-Ming%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22Glioblastoma%20%28GBM%29%20is%20the%20most%20aggressive%20brain%20tumor%20and%20relapses%20after%20chemo-%20or%20radiotherapy%20in%20a%20short%20time.%20The%20anticancer%20drug%20temozolamide%20%28TMZ%29%20is%20commonly%20used%20for%20GBM%20treatment%2C%20but%20glioma%20stem-like%20cells%20%28GSCs%29%20often%20lead%20to%20drug%20resistance%20and%20therapeutic%20failure.%20To%20date%2C%20the%20mechanism%20of%20GSC%20formation%20in%20TMZ-treated%20GBM%20remains%20largely%20unknown.%20CCAAT%5C%2FEnhancer-binding%20protein%20delta%20%28CEBPD%29%20is%20an%20inflammation-responsive%20transcription%20factor%20and%20is%20proposed%20to%20be%20oncogenic%20in%20the%20context%20of%20drug%20resistance%2C%20prompting%20us%20to%20clarify%20its%20role%20in%20TMZ-resistant%20GBM.%20In%20this%20study%2C%20we%20first%20found%20that%20the%20CEBPD%20protein%20levels%20in%20GBM%20patients%20were%20significantly%20increased%20and%20further%20contributed%20to%20TMZ%20resistance%20by%20promoting%20GSC%20formation.%20Accordingly%2C%20the%20protein%20levels%20of%20stemness%20transcription%20factors%2C%20namely%2C%20SRY-box%20transcription%20factor%202%20%28SOX2%29%2C%20octamer-binding%20transcription%20factor%204%20%28OCT4%29%2C%20NANOG%2C%20and%20ATP-binding%20cassette%20subfamily%20A%20member%201%20%28ABCA1%29%2C%20were%20increased%20in%20GSCs%20and%20TMZ-treated%20GBM%20cells.%20Increased%20binding%20of%20CEBPD%20to%20promoter%20regions%20was%20observed%20in%20GSCs%2C%20indicating%20the%20direct%20regulation%20of%20these%20GSC-related%20genes%20by%20CEBPD.%20In%20addition%2C%20an%20ABCA1%20inhibitor%20increased%20the%20caspase%203%5C%2F7%20activity%20of%20TMZ-treated%20GSCs%2C%20suggesting%20that%20TMZ%20efflux%20is%20controlled%20by%20ABCA1%20activity%20and%20that%20the%20expression%20levels%20of%20the%20ABCA1%20gene%20are%20an%20indicator%20of%20the%20efficiency%20of%20TMZ%20treatment.%20Together%2C%20we%20revealed%20the%20mechanism%20of%20CEBPD-mediated%20GSC%20drug%20resistance%20and%20proposed%20ABCA1%20inhibition%20as%20a%20potential%20strategy%20for%20the%20treatment%20of%20TMZ-resistant%20GBM.%22%2C%22date%22%3A%222021-01-12%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41420-020-00399-4%22%2C%22ISSN%22%3A%222058-7716%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41420-020-00399-4%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-12T17%3A21%3A48Z%22%7D%7D%5D%7D
Wang, S.-M., Lin, W.-C., Lin, H.-Y., Chen, Y.-L., Ko, C.-Y., & Wang, J.-M. (2021). CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma. Cell Death Discovery, 7(1), 1–11. https://doi.org/10.1038/s41420-020-00399-4 Cite
